Patents by Inventor Kristin K. Baldwin

Kristin K. Baldwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20230183238
    Abstract: Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
    Type: Application
    Filed: February 3, 2023
    Publication date: June 15, 2023
    Inventors: Pavel Osten, Kristin K. Baldwin, Robert DeVita, Samuel Desjardins, Jeffrey Albert
  • Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders
    Patent number: 11597726
    Abstract: Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: March 7, 2023
    Assignee: Certego Therapeutics Inc.
    Inventors: Pavel Osten, Kristin K. Baldwin, Robert DeVita, Samuel Desjardins, Jeffrey Albert
  • RING DEUTERATED GABOXADOL AND ITS USE FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20220127261
    Abstract: Ring deuterated gaboxadol is provided. The ring deuterated gaboxadol is useful in the treatment of psychiatric disorders and is more effective than non-deuterated gaboxadol in such treatments. Deuterated gaboxadol is useful in combinations with other compounds to provide additive and synergistic effects for patient therapies. In a specific embodiment, the deuterated gaboxadol is d6-gaboxadol.
    Type: Application
    Filed: May 20, 2021
    Publication date: April 28, 2022
    Inventors: Pavel Osten, Kristin K. Baldwin, Robert DeVita, Sam Desjardins, Jeffrey Albert
  • ADULT ANIMALS GENERATED FROM INDUCED PLURIPOTENT CELLS
    Publication number: 20120178158
    Abstract: The present invention provides methods and compositions for generating and using induced pluripotent stem cells.
    Type: Application
    Filed: June 23, 2010
    Publication date: July 12, 2012
    Applicant: The Scripps Research Institute
    Inventor: Kristin K. Baldwin